Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer

Margaret R. Spitz, R. Sue McPherson, Hong Jiang, T. C. Hsu, Zoltan Trizna, J. Jack Lee, Scott M. Lippman, Fadlo R. Khuri, Lyn Steffen-Batey, Robert M. Chamberlain, Stimson P. Schantz, Waun K. Hong

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

Although tobacco and alcohol use are the major determinants of upper aerodigestive tract carcinogenesis, not all smokers develop cancer. This phenomenon is due to individual variations in genetic susceptibility to carcinogens. One explanation may be differences in mutagen sensitivity (as measured by the in vitro bleomycin-induced mutagen sensitivity assay) in patients with squamous cell carcinoma of the upper aerodigestive tract. Antioxidant supplementation has also been shown to decrease DNA damage and thus may also inhibit carcinogenesis. In this study, we examined whether smoking, alcohol intake, and dietary antioxidant intake were correlated with mutagen sensitivity. The 612 patients evaluated are part of an ongoing multicenter Phase III trial of 13-cis retinoic acid for the prevention of second primary tumors. We found that patients with pharyngeal cancers were more likely than patients with oral cavity or larynx cancers to be mutagen sensitive. There were no significant differences in the distribution of mutagen sensitivity by sex or alcohol use. Never smokers were significantly more likely (61.1%) to be mutagen sensitive than current smokers (35.6%). Dietary consumption of the micronutrients α-carotene, β-carotene, lutein, lycopene, and vitamin C was not correlated with mutagen sensitivity. Therefore, we suggest that mutagen sensitivity is an independent marker of cancer risk not affected by other known risk factors.

Original languageEnglish (US)
Pages (from-to)687-692
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume6
Issue number9
StatePublished - 1997

Fingerprint Dive into the research topics of 'Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer'. Together they form a unique fingerprint.

  • Cite this

    Spitz, M. R., Sue McPherson, R., Jiang, H., Hsu, T. C., Trizna, Z., Lee, J. J., Lippman, S. M., Khuri, F. R., Steffen-Batey, L., Chamberlain, R. M., Schantz, S. P., & Hong, W. K. (1997). Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiology Biomarkers and Prevention, 6(9), 687-692.